OmniComm Systems’ TrialMaster EDC solution has been selected by a top five pharmaceutical company to run a five-year, late-phase oncology trial. The TrialMaster EDC Suite is a comprehensive solution aimed at simplifying clinical trial processes such as enhanced efficiencies and streamlined clinical operations across each stage of a trial.
"We are pleased that this high profile organization, a leader in the oncology space, recognizes the high quality services that OmniComm provides and the innovations that our TrialMaster technology offers," said Stephen Johnson, president and chief operating officer of OmniComm Systems. "Centralized monitoring with auto-redaction and an automated SDTM export utility were two of the key elements that secured our selection. We look forward to leveraging these innovative features to help drive down research costs and shorten study timelines."